InterventionsHuman trial

Efficacy and Safety of a Novel Oral Small Molecule GLP-1RA in Chinese Obese Adults without Diabetes

ADA Scientific Sessions 2025 Abstract

The paper

Weijun Gu, Lihui Zhang, Ling Li,

Wei Dong, Qifu Li, Yicen Zong, Chang Shu, Wei Dai,

Shijiazhuang

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Poster 865-P

doi.org/10.2337/db25-865-p

A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026